CROSSOVER I. SCSP NEXTECH - 20 Dec 2024 Form 3 Insider Report for Mersana Therapeutics, Inc. (MRSN)

Role
10%+ Owner
Signature
Nextech Crossover I SCSp, By Nextech Crossover I GP S.a r.l., its General Partner, By /s/ Ian Charoub and /s/ Costas Constantinides, Managers
Issuer symbol
MRSN
Transactions as of
20 Dec 2024
Net transactions value
$0
Form type
3
Filing time
30 Dec 2024, 16:12:17 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRSN Common Stock 12,067,246 20 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held of record by Nextech Crossover I SCSp ("Nextech Crossover LP"). Nextech Crossover I GP S.a. r.l. ("Nextech Crossover GP") is the general partner of Nextech Crossover LP and Ian Charoub, Costas Constantinides and Rocco Sgobbo are Managers of Nextech Crossover GP. Nextech Crossover GP and Messrs. Charoub, Constantinides and Sgobbo may be deemed to share voting and investment power with respect to the securities reported herein and disclaim beneficial ownership over such securities, except to the extent of its or his respective pecuniary interest therein, if any.

Remarks:

The Reporting Persons became the beneficial owners of greater than 10% of the Issuer's outstanding common stock as a result of a decrease in the number of shares outstanding, as described in the Issuer's Current Report on Form 8-K filed with the SEC on December 19, 2024, and not as a result of the acquisition of any securities by the Reporting Persons.